TipHub

BSE · 524640

Archit Organosys Ltd.

₹67.66
₹139 Cr market cap
P/E
356.11
EPS
₹0.19
Book value
₹31.26
ROE
116.49%
ROCE
3.9%
Debt / equity
0.46

Revenue & net profit by period

Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.

0163247.9963.99Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Revenue (₹ Cr) Net profit (₹ Cr)

Latest period: revenue ₹64 Cr with net profit ₹2 Cr — a 2.41% net margin, versus 3.91% the period before.

Shareholding

As of 2026-09-30

65.88%
promoter holding
  • Promoter65.88%
  • Public34.12%

8,512 shareholders on record

Promoter holding trend

Each disclosed period, oldest to newest

64.84%65.88%Dec 24Sep 26

52-week position

Where the current price sits in its yearly band

₹34₹67.66₹72

The band spans 2.12× from low to high.

Risk flags

Derived from disclosed data

No flags raised by the data.

Peer comparison

Chemicals · ranked #108 of 161 by market cap · medians across 50 industry peers

P/E
356.11vs 33 peer med
P/B
2.16vs 3.4 peer med
ROE %
116.49vs 11.89 peer med
Margin %
288.89vs 9.43 peer med
CompanyMkt capP/EP/BROEMargin
Solar Industries India Ltd.₹1,74,990 Cr77.3122.6329.5%17.7%
Pidilite Industries Ltd.₹1,55,399 Cr57.913.8823.94%16.63%
SRF Ltd.₹73,365 Cr31.064.7914.92%12.76%
Linde India Limited₹58,424 Cr118.2113.3111.26%18.08%
Gujarat Fluorochemicals Ltd.₹51,762 Cr75.936.177.97%11.43%
Navin Fluorine International Ltd.₹51,325 Cr56.0211.5320.41%22.4%
Godrej Industries Ltd.₹37,631 Cr30.763.3812.38%5.85%
Himadri Speciality Chem Limited₹28,241 Cr33.045.516.65%15.28%
Aether Industries Limited₹22,263 Cr88.328.589.61%19.21%
Deepak Nitrite Ltd.₹21,747 Cr20.33.3616.4%10.9%
Archit Organosys Ltd.(this company)₹139 Cr356.112.161.16%2.89%

AI analysis

AI-generated · google/gemini-2.5-flash

Archit Organosys Ltd. is listed on the Indian markets with a market capitalization of Rs 113 Cr. The company reported revenue of Rs 115.64 Cr and a profit margin of 288.9%. Its earnings per share (EPS) stands at Rs 0.19.

Positives

  • +The company's return on equity (ROE) is 116.5%.
  • +Promoter shareholding is 65.8792%, indicating a significant stake.
  • +The debt-to-equity ratio is 0.46.

Negatives

  • −The price-to-earnings (PE) ratio is high at 289.32.
  • −The return on capital employed (ROCE) is relatively low at 3.8967%.
  • −Net profit in Q4 Mar 2024 was negative at -Rs 0.46 Cr.
  • −The stock is currently under ESM Stage 1 surveillance measures.

Financial Performance

Archit Organosys Ltd. reported total revenue of Rs 115.64 Cr. The company's net profit margin was 288.9%. Over the last four quarters (March 2025 to March 2026), revenue has fluctuated, with the highest in Dec 2025 at Rs 38.4 Cr and the lowest in Sept 2025 at Rs 32.86 Cr. Net profit for the same period ranged from Rs 1.54 Cr in Sept 2025 to Rs 2.43 Cr in Dec 2025.

Profitability & Returns

The company's return on equity (ROE) is 116.5%, while the return on capital employed (ROCE) is 3.8967%. Earnings per share (EPS) is reported at Rs 0.19. The price-to-earnings (PE) ratio stands at 289.32.

Balance Sheet

Archit Organosys Ltd. has a book value of Rs 31.26. The debt-to-equity ratio is 0.46, indicating the extent of debt financing relative to equity. The company does not offer a dividend yield.

Ownership & Pledges

Public shareholding stands at 34.1208%. There are no shares pledged by the promoters. The company has a total of 9446 shareholders.

Regulatory & Surveillance

Archit Organosys Ltd. is currently under ESM (Enhanced Surveillance Measure) Stage 1. This measure is implemented to enhance market integrity and to protect the interests of investors.

Data as of — price: 2026-11-14 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.

How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.

Back to Archit Organosys Ltd.share price & fundamentals